Helix BioPharma Corp. (HBPCF)
OTCMKTS
· Delayed Price · Currency is USD
0.4500
0.00 (0.00%)
Apr 22, 2025, 4:00 PM EDT
Helix BioPharma Employees
Helix BioPharma had 7 employees as of July 31, 2024. The number of employees decreased by 2 or -22.22% compared to the previous year.
Employees
7
Change (1Y)
-2
Growth (1Y)
-22.22%
Revenue / Employee
n/a
Profits / Employee
-$969,187
Market Cap
29.56M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Endo Inc. | 3,116 |
| Northwest Biotherapeutics | 25 |
| Elite Pharmaceuticals | 64 |
| Glass House Brands | 374 |
| CytoDyn | 9 |
| American Oncology Network | 1,914 |
| Longduoduo Company | 49 |
Helix BioPharma News
- 13 days ago - Helix BioPharma Corp. Appoints Dr. Thomas Mehrling as Chief Executive Officer to Drive Ambitious Clinical Development Plan - TheNewswire
- 19 days ago - Urgent Solutions to Fight Cancer: How Helix BioPharma is Tackling the Toughest Challenges - IBTimes
- 20 days ago - Helix BioPharma Corp. Announces Engagement of Independent Trading Group to Provide Market-Making Services - TheNewswire
- 4 weeks ago - Helix BioPharma Corp. Announces Voting Results from its Annual General and Special Meeting - TheNewswire
- 5 weeks ago - Helix BioPharma Corp. Announces Filing of Interim Financial Statements as of and for the Three and Six Month Periods Ended January 31, 2025 - TheNewswire
- 6 weeks ago - Helix BioPharma Corp. Announces Upcoming Poster Presentation at the 20th European Molecular Imaging Meeting in Bilbao, Spain - TheNewswire
- 6 weeks ago - Helix Biopharma Corp. Expands Leadership Team with World-Class Oncology and Scientific Experts - TheNewswire
- 7 weeks ago - Helix BioPharma Corp. receives approval for the Extension of Annual General and Special Meeting to Seek Approval of Asset Acquisitions and Proposed Financing - TheNewswire